The study results suggested that MK has showed 27% reduction in the area of heart muscle damage as compared to untreated animals undergoing the same procedure.
Dose-ranging studies demonstrated that MK was effective at reducing heart muscle death with doses between 0.1mg/kg and 1.0 mg/kg.
Moreover, MK was safe and well tolerated at doses 16 times greater than the most effective dose of 0.18 mg/kg, with no cardiovascular toxicities observed.